Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001187325-04-000001
Filing Date
2004-05-28
Accepted
2004-05-28 15:33:27
Documents
1
Period of Report
2004-05-26

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3878
  Complete submission text file 0001187325-04-000001.txt   5593
Mailing Address 3172 PORTER DRIVE PALO ALTO CA 94304
Business Address 3172 PORTER DR PALO ALTO CA 94304 6503848500
CV THERAPEUTICS INC (Issuer) CIK: 0000921506 (see all company filings)

EIN.: 431570294 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address 904 CARIBBEAN DRIVE SUNNYVALE CA 94089 4084008251
GUTSHALL THOMAS L (Reporting) CIK: 0001187325 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21643 | Film No.: 04838402